About the Job

We are an innovative global healthcare company with one purpose: to chase the miracles of science to improve people’s lives. We’re also a company where you can flourish and grow your career, with countless opportunities to explore, make connections with people, and stretch the limits of what you thought was possible. Ready to get started?

Job Overview:

The 2025 Spring Co-Op will work in the downstream process development group of the drug substance function in Recombinant Mammalian Science, Analytics, and Technology (MSAT). The co-op will work in a laboratory setting on a project related to protein purification process characterization and protein drug substance stability. This position is 6 months on a full-time basis January 2025 – June 2025.

The drug substance function within Recombinant Mammalian Science, Analytics, and Technology (MSAT) is the owner of Life Cycle Management (LCM) of DS Processes within Sanofi biologics manufacturing network. We deliver innovative, robust, and cost-effective next generation processes and provide commercial manufacturing support. The function is responsible for tech transfer activities including process fit-gap assessment, process validation, prepare dossier sections, & PAI support to enable launch of new and LCM products. Our expansive portfolio covers 17 products, 5 modalities, 3 expression systems within 12 internal and external global sites in US and EU. We will be supporting launch of 20 new products in next 5 years including monoclonal and multi-specific antibodies, fusion proteins, antibody-drug conjugates, synthorins and nanobodies. In recent years we have successfully established second-generation manufacturing process with a continuous process platform. We are pursuing future innovations such as digital labs, factories of future and advanced analytics-based process understanding and control.

**At this time, Sanofi will not sponsor a new applicant for employment authorization or offer any immigration related support for this position (i.e. H1B, F-1 OPT, F-1 STEM OPT, F-1 CPT, J-1, TN, or another type of work authorization). ** 

Responsibilities:

Work on an MSAT development project, to include execution of chromatography and filtration operations, protein stability studies, analytical testing, and data analysis.

Collaborate with the MSAT project team; attend regular team meetings and share study progress and results.

Participate in design and execution of experiments using small-scale models, analyze and interpret results, and recommend additional experiments.

Author internal presentations, protocols, and technical reports, as applicable.

About you

Basic Qualifications:

Currently pursuing a Bachelor's or Master's degree in Chemical Engineering, Biochemistry, Biotechnology, or related discipline at an accredited college or university with the expectation that you will complete your current degree by the Spring of 2027   

Must be enrolled in school the semester following your internship/co-op with Sanofi.  

Must be able to relocate to the office location and work 40hrs/week, Monday-Friday, for the full duration of the co-op/internship (UNLESS REMOTE OR PARTIME FALL OR SPRING COOP) 

Must have permanent US work authorization 

Preferred Qualifications:

Experience in a biotechnology or pharmaceutical industry laboratory setting

Experience with downstream processes at lab, pilot, or production scale including chromatography (e.g. AKTA), tangential flow filtration, or nanofiltration

Knowledge in protein stability studies and routine protein analytical techniques

Strong technical writing and presentation skills

Why Choose Us?

Bring the miracles of science to life alongside a supportive, future-focused team.

Discover endless opportunities to grow your talent and drive your career, whether it’s through a promotion or lateral move, at home or internationally.

Enjoy a thoughtful, well-crafted rewards package that recognizes your contribution and amplifies your impact.

Take good care of yourself and your family, with a wide range of health and wellbeing benefits including high-quality healthcare, prevention and wellness programs and at least 14 weeks’ gender-neutral parental leave.

Sanofi Inc. and its U.S. affiliates are Equal Opportunity and Affirmative Action employers committed to a culturally diverse workforce. All qualified applicants will receive consideration for employment without regard to race; color; creed; religion; national origin; age; ancestry; nationality; marital, domestic partnership or civil union status; sex, gender, gender identity or expression; affectional or sexual orientation; disability; veteran or military status or liability for military status; domestic violence victim status; atypical cellular or blood trait; genetic information (including the refusal to submit to genetic testing) or any other characteristic protected by law.

#GD-SG 
#LI-GZ
#LI-Onsite
#vhd​

Better is out there. Better medications, better outcomes, better science. But progress doesn’t happen without people – people from different backgrounds, in different locations, doing different roles, all united by one thing: a desire to make miracles happen. So, let’s be those people.

At Sanofi, we provide equal opportunities to all regardless of race, colour, ancestry, religion, sex, national origin, sexual orientation, age, citizenship, marital status, ability or gender identity.

Watch our ALL IN video and check out our Diversity Equity and Inclusion actions at sanofi.com!

US and Puerto Rico Residents Only

Sanofi Inc. and its U.S. affiliates are Equal Opportunity and Affirmative Action employers committed to a culturally inclusive and diverse workforce. All qualified applicants will receive consideration for employment without regard to race; color; creed; religion; national origin; age; ancestry; nationality; natural or protective hairstyles; marital, domestic partnership or civil union status; sex, gender, gender identity or expression; affectional or sexual orientation; disability; veteran or military status or liability for military status; domestic violence victim status; atypical cellular or blood trait; genetic information (including the refusal to submit to genetic testing) or any other characteristic protected by law.